Editorial Archives - Page 93 of 122 - ExecEdge

Comera Study Shows Caffeine’s Ability to Reduce Viscosity in Antibodies

Comera Study Shows Caffeine’s Ability to Reduce Viscosity in Antibodies

By Daniella Parra Comera Life Sciences Holdings (Nasdaq: CMRA) said it published data showing caffeine’s potential to reduce viscosity in subcutaneous formulations of monoclonal antibodies. The studies demonstrated caffeine’s positive influence on pharmacokinetics and its compatibility with monoclonal antibody ipilimumab,...

TechMet Reports Closing of $200 Million Equity Raise

TechMet Reports Closing of $200 Million Equity Raise

By Daniella Parra TechMet said it closed its latest $200 million equity fundraising round and is set to exceed a billion-dollar valuation in the next few months. The global critical minerals investment company said the funds will help develop and...

Abacus Life Second Quarter Revenue Jumps 30%

Abacus Life Second Quarter Revenue Jumps 30%

By Daniella Parra Abacus Life, Inc. (NASDAQ: ABL) said second quarter revenue climbed 30 percent from a year earlier to $18.3 Million. The life insurance policy specialist said net income increased 40%, while adjusted EBITDA grew 33 percent to $8.8...

Input your search keywords and press Enter.